Search Protocols under revision. Back New search Go to resultsDiseaseMain groupHematologic NeoplasmsProtocol groupT-Cell and NK-Cell NeoplasmsDiseaseNHL, T-cell type, extranodal NK/T-cell Lymphoma, nasal typeNHL, T-cell type; other specified NK/T-cell lymphomasSubgroupICD10C86.-C86.0MeSHLymphoma, Extranodal NK-T-CellLymphoma, T-Cell, PeripheralSequenceChemotherapyChemo-substanceAsparaginaseCarboplatinCisplatinDexamethasoneEtoposideGemcitabineIfosfamideMethotrexatePeg asparaginaseChemo-substanceAsparaginaseCarboplatinCisplatinDexamethasoneEtoposideGemcitabineIfosfamideMethotrexatePeg asparaginaseChemo-substanceAsparaginaseCarboplatinCisplatinDexamethasoneEtoposideGemcitabineIfosfamideMethotrexatePeg asparaginaseChemo-substanceAsparaginaseCarboplatinCisplatinDexamethasoneEtoposideGemcitabineIfosfamideMethotrexatePeg asparaginaseNo. Substances45 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneDextrose 5%DimetindenFamotidineFilgrastimFolinic acidFosaprepitantFurosemideGranisetronMagnesium sulfateMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chlorideSodium BicarbonateSupportive substanceBalanced Crystalloid SolutionDexamethasoneDextrose 5%DimetindenFamotidineFilgrastimFolinic acidFosaprepitantFurosemideGranisetronMagnesium sulfateMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chlorideSodium BicarbonateSupportive substanceBalanced Crystalloid SolutionDexamethasoneDextrose 5%DimetindenFamotidineFilgrastimFolinic acidFosaprepitantFurosemideGranisetronMagnesium sulfateMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chlorideSodium BicarbonateSupportive substanceBalanced Crystalloid SolutionDexamethasoneDextrose 5%DimetindenFamotidineFilgrastimFolinic acidFosaprepitantFurosemideGranisetronMagnesium sulfateMesnaNaCl 0.9%ParacetamolPegfilgrastimPotassium chlorideSodium BicarbonateNo. Substances51011Protocol classificationTherapy classificationcurrent standardIntensityhigh doseStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksAnemia Hb below 8g/dlConjunctivitisDiarrheaDysphagiaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaHyperbilirubinemiaHyperglycemiaHypoalbuminemiaHyponatremiaIncrease AminotransferasesInfectionsLeukopeniaMucositisNeutropeniaRashThrombocytopenia below 50 000/µl only studiesPublicationAuthorLi XYamaguchi MDiseaseExtranodales NK/T-Zell Lymphom, Stadium III-IV, ErstlinieExtranodales NK/T-Zell Lymphom, Stadium III-IV, Erstlinie, ECOG 0-2OriginDepartment of Oncology, The First Affiliated Hospital of Zhengzhou UniversityMie University Graduate School of Medicine, Tsu, JapanMie University Graduate School of Medicine, Tsu, Japan, JCOG0211Protocols in Revision 3 protocols foundDDGP - Cisplatin 20 / Gemcitabine 800 / PEG-Asparaginase 2500 / Dexamethasone 15, extranodal NK/T-cell Lymphoma (PID2349 V1.1)DeVIC - Dexamethasone 40 / Etoposide 67 / Ifosfamide 1 / Carboplatin 200 / Radiation, extranodal NK/T-cell Lymphoma (PID3192 V1.0)SMILE - Methotrexate 2000 / Ifosfamide 1.5 / Dexamethasone 40 / Etoposide 100 / Asparaginase 6000, extranodal NK/T-cell Lymphoma (PID2351 V1.1)
